UAMS Breast Cancer Awareness Program Receives Grant from Avon Foundation
| LITTLE ROCK – The Witness Project, a program of the The Witness Project, sponsored by the UAMS College of Public Health and founded by the Winthrop P. Rockefeller Cancer Institute, educates African-American and medically underserved women and refers them to low-cost or free mammograms and clinical breast exams in their communities. Mobile mammography units provide screenings for women living in counties with limited access to certified mammography facilities. The program also assists women with transportation and other unmet needs. Educational programs are presented at churches, civic centers, job sites and during community activities. In the past five years, The Witness Project has educated and assisted more than 12,000 women in 23 The Witness Project was featured on CNN Headline News in October 2006, was the recipient of the Arkansas Women of Essence Award for 2007 and was one of the beneficiaries of The Breast Cancer Dance Project for 2007. Breast cancer is the most common form of cancer in women in the Nationwide, there is a new diagnosis every three minutes and a death from breast cancer every 14 minutes. While advances have been made in prevention, diagnosis, treatment and cure, early detection still affords the best opportunity for successful treatment. Programs such as The Witness Project help ensure that all women have access to early detection information and options, even economically disadvantaged and medically underserved women. “We are proud that the Avon Foundation shares the mission of The Witness Project. With these funds, The Witness Project will be able to reach more ladies in The Avon Foundation Inc. has funded community-based programs designed to improve utilization of regular breast cancer screening by at-risk populations (minority and under-insured) since 1993. The Witness Project at UAMS and other programs are dedicated to educating underserved women about breast cancer and linking them to early detection screening services. The Avon Foundation, an accredited 501(c)(3) public charity, was founded in 1955 to improve the lives of women and their families. Now past the half-century milestone, the foundation brings this mission to life through the Speak Out Against Domestic Violence program and the Avon Breast Cancer Crusade, which raises funds and awareness to advance access to care and finding a cure for breast cancer, with a focus on the medically underserved. Since 1992 the Avon Breast Cancer Crusade has raised and awarded more than $450 million worldwide for medical research; access to care; support services; screening and diagnostics; and education and awareness. The largest fundraising program in the The The Avon Foundation Breast Care Fund is administered by Cicatelli Associates Inc. to support community-based, nonprofit breast health programs across the country. The fund’s National Advisory Board selected The Witness Project at UAMS as one of 2008 new grant recipients nationwide in the 2008 cycle of Avon Foundation Breast Care Fund grants. These organizations were chosen based on their ability to effectively reach women, particularly minority, low-income and older women, who are often medically underserved. For information on The Witness Project, call Charlie Stayton at (800) 275-1183 or (501) 661-9603. For information about breast cancer, contact the American Cancer Society at (800) ACS-2345 or www.cancer.org, or the National Cancer Institute at (800) 4-CANCER or www.cancer.gov. To learn more about the Avon Foundation, call (866) 505-AVON or visit www.avonfoundation.org, where you can also access the free printable Breast Health. UAMS is the state’s only comprehensive academic health center, with five colleges, a graduate school, a medical center, six centers of excellence and a statewide network of regional centers. UAMS has 2,538 students and 733 medical residents. Its centers of excellence include the Winthrop P. Rockefeller Cancer Institute, the Jackson T. Stephens Spine & Neurosciences Institute, the Myeloma Institute for Research and Therapy, the
The